BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29954633)

  • 1. A comparison of different surfactants on foam stability in foam sclerotherapy in vitro.
    Bai T; Liu Y; Liu J; Yu C; Jiang W; Fan Y
    J Vasc Surg; 2019 Feb; 69(2):581-591.e1. PubMed ID: 29954633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Multiple Factors on Foam Stability in Foam Sclerotherapy.
    Bai T; Jiang W; Chen Y; Yan F; Xu Z; Fan Y
    Sci Rep; 2018 Oct; 8(1):15683. PubMed ID: 30356108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties of polidocanol foam in view of its use in sclerotherapy.
    Nastasa V; Samaras K; Ampatzidis Ch; Karapantsios TD; Trelles MA; Moreno-Moraga J; Smarandache A; Pascu ML
    Int J Pharm; 2015 Jan; 478(2):588-96. PubMed ID: 25433198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on Foam Decay Trend and Influence of Temperature Jump on Foam Stability in Sclerotherapy.
    Bai T; Chen Y; Jiang W; Yan F; Fan Y
    Vasc Endovascular Surg; 2018 Feb; 52(2):98-106. PubMed ID: 29173136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Review of Sclerosing Foam Stability in the Treatment of Varicose Veins.
    Bai T; Liu Y; Jiang W; Li Y; Liu J; Yu C; Fan Y
    Dermatol Surg; 2020 Feb; 46(2):249-257. PubMed ID: 31569112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleomycin Polidocanol Foam (BPF) Stability - In Vitro Evidence for the Effectiveness of a Novel Sclerosant for Venous Malformations.
    Sun Y; Gu H; Yang X; Cai R; Shang Y; Hu L; Wang Y; Chen H; Lin X
    Eur J Vasc Endovasc Surg; 2020 Jun; 59(6):1011-1018. PubMed ID: 32063463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Investigation on the Influence of Hyaluronic Acid on Polidocanol Foam Stability.
    Chen AW; Liu YR; Li K; Liu SH
    Dermatol Surg; 2016 Jan; 42(1):56-8. PubMed ID: 26671207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of foam in sclerotherapy: differences between sodium tetradecyl sulfate and polidocanol and the type of connector used in the double-syringe system technique.
    Rao J; Goldman MP
    Dermatol Surg; 2005 Jan; 31(1):19-22. PubMed ID: 15720090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polidocanol foam stability in terms of its association with glycerin.
    Rial R; Hervas LS; Monux G; Galindo A; Martin A; Hernando M; Martinez I; Hernando A; Serrano FJ
    Phlebology; 2014 Jun; 29(5):304-9. PubMed ID: 23470491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Syringe Volume on Foam Stability in Sclerotherapy for Varicose Vein Treatment.
    Bai T; Jiang W; Fan Y
    Dermatol Surg; 2018 May; 44(5):689-696. PubMed ID: 29140865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits of polidocanol endovenous microfoam (Varithena®) compared with physician-compounded foams.
    Carugo D; Ankrett DN; Zhao X; Zhang X; Hill M; O'Byrne V; Hoad J; Arif M; Wright DD; Lewis AL
    Phlebology; 2016 May; 31(4):283-95. PubMed ID: 26036246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Pushing Rate on Foam Stability in the Tessari Method.
    Azmoun S; Liu Y; Bian K; Chen A; Liu S
    Dermatol Surg; 2024 Jun; 50(6):542-545. PubMed ID: 38460194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new method for using radiopaque sclerosing foam to treat venous malformations.
    Li K; Liu YR; Chen AW; Liu SH
    Dermatol Surg; 2015 Jun; 41(6):726-30. PubMed ID: 25973562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Optical Method for Immediate Evaluation of Microfoam Stability in Foam Sclerotherapy.
    Bai T; Jiang W; Liang L; Li Y; Fan Y
    Skin Pharmacol Physiol; 2021; 34(3):128-134. PubMed ID: 33794544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Foam sclerosants are more stable at lower temperatures.
    Valenzuela GC; Wong K; Connor DE; Behnia M; Parsi K
    Eur J Vasc Endovasc Surg; 2013 Nov; 46(5):593-9. PubMed ID: 24070851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative stability of sodium tetradecyl sulphate (STD) and polidocanol foam: impact on vein damage in an in-vitro model.
    McAree B; Ikponmwosa A; Brockbank K; Abbott C; Homer-Vanniasinkam S; Gough MJ
    Eur J Vasc Endovasc Surg; 2012 Jun; 43(6):721-5. PubMed ID: 22507925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel developments in foam sclerotherapy: Focus on Varithena® (polidocanol endovenous microfoam) in the management of varicose veins.
    Star P; Connor DE; Parsi K
    Phlebology; 2018 Apr; 33(3):150-162. PubMed ID: 28166694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of stability of polidocanol foam for nonsurgical permanent contraception.
    Guo JX; Lucchesi L; Gregory KW
    Contraception; 2015 Aug; 92(2):103-7. PubMed ID: 26070858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sulodexide on stability of sclerosing foams.
    Critello CD; Fiorillo AS; Cristiano MC; de Franciscis S; Serra R
    Phlebology; 2019 Apr; 34(3):191-200. PubMed ID: 29871533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the relative silicone content of different syringes affect the stability of foam in sclerotherapy?
    Lai SW; Goldman MP
    J Drugs Dermatol; 2008 Apr; 7(4):399-400. PubMed ID: 18459524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.